CEPI | New Vaccines For A Safer World

New COVAX Marketplace to accelerate COVID-19 vaccine production

The innovative platform will match suppliers of critical inputs with vaccine manufacturers who urgently need them to produce vaccines for fair and equitable distribution through COVAX.

Learn more

We want to create a world in which epidemics are no longer a threat to humanity.

CEPI wants to galvanise the development of new vaccines against diseases we know could cause the next devastating epidemic.

Our approach

$570bn

The estimated annual global cost of moderately severe to severe pandemics

Eleven

The number of diseases WHO identified as public health risks due to epidemic potential and lack of biomedical countermeasures

$2.8bn

The minimum average cost for progressing one vaccine against each of WHO’s 11 priority epidemic infectious diseases

Epidemic diseases affect us all. They do not respect borders.

CEPI (pronounced 'seppy') aims to accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks.

Who we are

Ahmedabad, India (Paula Bronstein/Getty Images Reportage)

Get involved

Our work

Our portfolio